20) in cash per share tender offer to buy diabetes-focused biopharmaceutical firm Amylin
Pharmaceuticals Inc (NASDAQ:AMLN), to run until 7 August, the buyer said today.
In their extension of a 28-week Phase II dose-ranging study, Takeda and Amylin
note that patients who continued treatment with pramlintide/metreleptin for 52 weeks demonstrated sustained weight loss, whereas those continuing on a placebo regained almost all of their weight.
We are looking forward to working with the team at Amylin
to build on their success and maximize AstraZeneca's and Bristol-Myers Squibb's combined capabilities to make these innovative treatments available to many more diabetes patients across the world.
Global biopharmaceutical company Bristol-Myers Squibb Company (NYSE:BMY) and Amylin
Pharmaceuticals Inc (Nasdaq:AMLN) announced on Friday that Bristol-Myers Squibb will acquire Amylin
4bn in cash to Amylin
as a fully-owned unit of Bristol-Myers Squibb, with profits and losses to be equally shared.
As part of the successful completion of the tender offer, Bristol-Myers Squibb has exercised its right, granted under the merger agreement with Amylin
pursuant to which the tender offer was made, to purchase additional shares from Amylin
which will allow Bristol-Myers Squibb to complete and close the merger and acquisition of Amylin
today without stockholder approval.
Prior to Amylin
, he was engaged in marketing and sales roles at SmithKline Beecham Pharmaceuticals.
According to sources of Bloomberg, Amylin
has already set out to woo buyers and Sanofi SA (EPA:SAN) is mulling over making an offer.
approval decision, is one of the most important drugs in Lilly's pipeline and the most critical future growth driver for Amylin
Managing diabetes is a daily struggle for millions of Americans," points out Ginger Graham, president and chief executive officer of San Diego-based Amylin
NEW YORK -- Bristol-Myers Squibb Company (NYSE: BMY) ("Bristol-Myers Squibb") announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended (HSR), for its tender offer for Amylin
M2 EQUITYBITES-August 10, 2012-Bristol-Myers Squibb acquires Amylin
Pharmaceuticals Inc at USD31.
28 March 2012 - US diabetes drugs maker Amylin
Pharmaceuticals Inc (NASDAQ:AMLN) has turned down a USD22.
M2 PHARMA-November 8, 2011-Lilly, Amylin
terminate diabetes collaboration, resolve outstanding litigation(C)2011 M2 COMMUNICATIONS
s (Indianapolis IN) and Amylin